PMID: 42499082

Therapeutic role of semaglutide in metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis: A systematic review and meta-analysis of placebo-controlled trials with GRADE evidence assessment.

Khan Suleman, Jamal Asad, Qadri Maria, Zai Ibrahim Aslam, Shah Asim, Ahmed Adil, Khalid Aizaz Anwar, Khan Abbas, Misbahuddin F N U, Iftikhar Hammad

Medicine · 2026

Vol. 105, Issue 30, pp. e49916

View on PubMed DOI

This entry links to third-party literature. For research use only.

SemaglutideGlucagon-Like PeptidesHumansNon-alcoholic Fatty Liver DiseaseRandomized Controlled Trials as TopicGlucagon-Like Peptide-1 Receptor AgonistsMetabolic Diseases

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.